Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
editorial
. 2001 Jun;39(6):2367–2368. doi: 10.1128/JCM.39.6.2367-2368.2001

Improved Primer Design for Multiplex PCR Analysis of Vancomycin-Resistant Enterococcus spp.

Sameer Elsayed 1,2,*, Nina Hamilton 1,2, David Boyd 1,2, Michael Mulvey 1,2
PMCID: PMC88151  PMID: 11414244

Kariyama and colleagues (5) recently described a multiplex PCR method for the detection of the vanA, vanB, vanC1, and vanC2/C3 genes, in addition to primers for the detection of the ddl genes of Enterococcus faecalis and E. faecium and of 16S rRNA (PCR control). However, the vanB primers used by these authors were derived from the sequence of the vanB1 subtype (1) and are incapable of detecting vanB2 or vanB3 subtypes, as previously described (2, 4, 7) and recently demonstrated in our laboratories.

Calgary Laboratory Services (CLS) recently implemented the PCR scheme described by Kariyama et al. (5). Three enterococcal strains which displayed a vancomycin-resistant enterococci phenotype were negative for the van genes using this methodology even though the ddlE. faecalis and 16S rRNA genes were amplified. PCR using the primer set for vanB alone yielded an amplicon of 1.1 kb for all three strains, which was larger than the expected 433 bp. The isolates were subsequently referred to the National Microbiology Laboratory (NML), Winnipeg, Manitoba, for further analysis. The NML has implemented a multiplex assay which uses novel, unpublished primers for the detection of vanB genes, the ddl genes of E. faecalis and E. faecium, and a published set of primers for the vanA gene (3). Using this assay, all three strains produced the E. faecalis-specific product and the vanB product. In order to explain the discordant results, the NML sequenced the 1.1-kb product produced using the Kariyama et al. (5) primer set. Sequence analysis revealed that the reverse primer bound correctly. However, the forward primer did not appear to anneal at the site 5′ GTG ACA AAC CGG AGG CGA GGA 3′ since the corresponding sequence of the vanB2 gene was 5′ GTG ACA AGC CGG AGG CGG GTG 3′. There are four nucleotide changes, with three of them at the 3-prime end, which likely results in no primer binding. This is predicted to also occur with the vanB3 gene (5′ GTG ACA AGC CGG AGA CGG GTG 3′). Further sequence analysis revealed that the forward primer is binding to the upstream vanH gene at the following site: 5′ GGA TGT GTT GGA GGG CGA GGA 3′. Note that the last 8 bp of this region and the forward primer used by Kariyama et al. (5) are identical. This primer binding would result in an amplicon of 1,086 bp, which is consistent with the PCR results.

The NML currently uses in-house primers developed from consensus vanB sequences (forward, 5′ AAG CTA TGC AAG AAG CCA TG 3′, and reverse, 5′ CCG ACA ATC AAA TCA TCC TC 3′) capable of detecting all vanB subtypes, with an amplicon size of approximately 536 bp. The multiplex assay described by Kariyama and colleagues (5) was easy to perform and reliably detected vanA, vanC1, vanC2/vanC3, and species-specific genes for E. faecalis and E. faecium from other isolates tested at both CLS and NML. However, if one were to substitute the vanB primers used by Kariyama et al. (5) with those developed by NML, the multiplex assay would be capable of detecting all vanB subtypes. Other vanB consensus primers have been developed (2); however, these primers cannot be used in the multiplex assay described by Kariyama et al. (5) since the vanC2 or vanC3 amplicon sizes would be identical.

In summary, the presence of vanB subtypes necessitates the use of consensus PCR primers for rapid and reliable detection. While the work was in progress Kawalec et al. (6) described similar results in a vanB2 E. faecium strain and determined that mispriming within vanH was responsible, though they did not precisely determine the anomalous primer binding site.

REFERENCES

  • 1.Clark N C, Cooksey R C, Hill B C, Swenson J M, Tenover F C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother. 1993;37:2311–2317. doi: 10.1128/aac.37.11.2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Dahl K H, Simonsen G S, Olsvik O, Sundsfjord A. Heterogeneity in the vanBgene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1999;43:1105–1110. doi: 10.1128/aac.43.5.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995;33:24–27. doi: 10.1128/jcm.33.1.24-27.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gold H S, Unal S, Cercenado E, Thauvin-Eliopoulos C T, Eliopoulos G M, Wennersten C B, Moellering R C., Jr A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanCgenes of enterococci. Antimicrob Agents Chemother. 1993;37:1604–1609. doi: 10.1128/aac.37.8.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kariyama R, Mitsuhata R, Chow J W, Clewell D B, Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol. 2000;38:3092–3095. doi: 10.1128/jcm.38.8.3092-3095.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kawalec M, Gniadkowski M, Zielinska U, Klos W, Hryniewicz W. Vancomycin-resistant Enterococcus faecium strain carrying the vanB2gene variant in a Polish hospital. J Clin Microbiol. 2001;39:811–815. doi: 10.1128/JCM.39.2.811-815.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Patel R, Uhl J R, Kohner P, Hopkins M K, Steckelberg J M, Kline B, Cockerill F R., III DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcusisolates. Antimicrob Agents Chemother. 1998;42:202–205. doi: 10.1128/aac.42.1.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
J Clin Microbiol. 2001 Jun;39(6):2367–2368. doi: 10.1128/JCM.39.6.2367-2368.2001

AUTHORS' REPLY

Reiko Kariyama 1, Ritsuko Mitsuhata 1, Hiromi Kumon 1

We thank Elsayed and colleagues for their implementation of our multiplex PCR scheme (1-2) and the primer design for consensus vanB sequences. We have one comment for their letter. The first sentence written by Elsayed and colleagues does not correctly describe our primers. The sentence “in addition to primers for the detection of the ddl genes of E. faecalis and E. faecium” should be changed to “in addition to primers for species-specific genes of E. faecalis and E. faecium.” In our article (1-2), the primer set for E. faecalis amplifies the ddl gene, but the primer set for E. faecium does not amplify the ddl gene (1-1).

We performed the multiplex PCR assay (1-2) by using a novel combination of primer sets which included a primer set for consensus vanB sequences (referred to here as vanB consensus primer set) designed by Elsayed and colleagues. We found that E. faecalis-specific amplification was inhibited by a novel primer combination with the vanB consensus primer set if we used the same primer concentrations as previously described (1-2). Then, we optimized the vanB consensus primer concentration, which was found to be one-half of the concentration previously described (1-2). As shown in Fig. 1-1, the best result was observed when the novel primer combination was added to the reaction mixtures at 5 pmol each of vanA, E. faecalis-specific primers; 2.5 pmol each of the vanC1, vanC2/C3, rrs primers; and 1.25 pmol each of the vanB, E. faecium-specific primers.

FIG. 1-1.

FIG. 1-1

Gel image generated by the Agilent 2100 bioanalyzer of amplified vanA, vanB, vanC1, vanC2/C3, E. faecalis-specific, E. faecium-specific, and rrs genes by the optimized multiplex PCR assay (1-2) containing a novel primer combination as described above. Lanes: M, DNA ladder; 1, an E. faecalis vanA isolate; 2, an E. faecalis vanA isolate; 3, an E. faecalis vanB isolate; 4, an E. faecalis vanB isolate; 5, an E. faecium vanA isolate; 6, an E. faecium vanA isolate; 7, an E. faecium vanB isolate; 8, an E. faecium vanB isolate; 9, an E. gallinarum vanC1 isolate; 10, an E. gallinarum vanC1 and vanA isolate; 11, an E. gallinarum vanC1 and vanB isolate; 12, an E. casseliflavus or E. flavescens vanC2 or vanC3 isolate.

Using the novel primer combination, vancomycin-resistant enterococci (low- to high-level resistance) from our collection were tested. For all isolates, PCR products with two or three intense bands on agarose gels were generated as shown previously (1-2). Of 139 isolates tested, 14 E. faecalis (vanA) isolates, 29 E. faecalis (vanB) isolates, 42 E. faecium (vanA) isolates, 9 E. faecium (vanB) isolates, 24 E. gallinarum (vanC1) isolates, 2 E. gallinarum (vanC1 and vanA) isolates, 2 E. gallinarum (vanC1 and vanB) isolates, and 17 E. casseliflavus or E. flavescens (vanC2 or vanC3) isolates were clearly identified. The results indicated that we missed four isolates possessing a vanB2 or vanB3 gene previously.

Figure 1-1 shows a gel image of PCR products obtained by the Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, Calif.) which utilizes chip-based nucleic acid separation technology (1-3). The LabChip7500 (Caliper Technologies, Mountain View, Calif.) was used to analyze PCR products. This instrument improves DNA analysis compared with agarose gel electrophoresis and is suitable for routine laboratories (1-3).

We appreciate Elsayed and colleagues, who designed the improved primer for consensus vanB sequences and gave us an opportunity to show new data obtained by the Agilent 2100 bioanalyzer. In summary, the novel primer combination using the optimized primer concentration described above is more reliable for the detection of vancomycin-resistant enterococci, since this combination detects all vanB subtypes.

REFERENCES

  • 1-1.Cheng S, McCleskey F K, Gress M J, Petroziello J M, Liu R, Namdari H, Beninga K, Salmen A, DelVecchio V G. A PCR assay for identification of Enterococcus faecium. J Clin Microbiol. 1997;35:1248–1250. doi: 10.1128/jcm.35.5.1248-1250.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 1-2.Kariyama R, Mitsuhata R, Chow J W, Clewell D B, Kumon H. Simple and reliable multiplex PCR assay for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol. 2000;38:3092–3095. doi: 10.1128/jcm.38.8.3092-3095.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 1-3.Nachamkin I, Panaro N J, Li M, Ung H, Yuen P K, Kricka L J, Wilding P. Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuniflagellin gene. J Clin Microbiol. 2001;39:754–757. doi: 10.1128/JCM.39.2.754-757.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES